Simedice: MOM Technology Intraocular Lenses Restoring Vision and Quality of Life for Cataract Patients Worldwide
Cataract surgery with intraocular lens (IOL) implantation is currently the most effective approach for managing cataracts. However, many IOLs available on the market often lead to issues such as postoperative residual refractive error and suboptimal visual quality, as well asPCO and other issues.
Selecting high-quality intraocular lenses can effectively prevent a significant proportion of similar postoperative complications. SymEyesThe MOM technology platform delivers stable, clear, and precise intraocular lenses (IOLs) through innovative material formulations, precise optical control, and injection molding technology. Crafted from acrylic material, the IOLs block ultraviolet light and a portion of blue light, effectively protecting the surgical eye from photic damage. The material’s low glistenings performance and excellent biocompatibility contribute to superior postoperative visual quality for patients. With rigorous optical design, precision manufacturing processes, and the elimination of traditional polishing, the product adheres to standards stricter than both domestic and international ISO requirements, thereby effectively reducing the incidence of posterior capsule opacification (PCO) and postoperative residual refractive error.
September 21Day (Thursday）19：30, VCBeat Selects New Product Tasting Session24phase, invitedGeneral Manager of Henan Saimeishi Biotechnology Co., Ltd.Shi Baona, Wang Yong, Vice President of Aier Eye Hospital Affiliated to Wuhan UniversityTogether Bringing Forth SimeishiMOM TechnologyIntraocular LensProduct Introduction.
>>>>
Materials
New material formula blocks a portion of harmful blue light to protect the retina. The posterior capsule exhibits excellent conformability, reducing rotation andPCO；Controlled folding and unfolding of the lens, easy to inject; Minimally invasive small incision. The large contact angle C-loop design enhances stability after intraocular lens implantation.
Optical Design
Precision optics with high contrast sensitivity in both daytime and nighttime. The world’s first spherical aberration-customized product, based on precise optical control.
Mold Injection Technology
The optical zone is formed by single-step molding, featuring polished-free square edges with right angles to preventPCO. Nanoscale injection molding technology ensures more precise optical surface profiles and clearer postoperative imaging.
>>>>
Stable Medical-stable
OptimizationType CLoopDesign, high mechanical stability
The hydrophobic properties of the material ensure excellent adhesion between the product and the posterior capsule of the lens.
Plasma Surface Treatment Technology, reduce postoperative inflammatory response
Excellent Low-Glare Performance
>>>>
Clear Sight
Blocks UV rays and harmful blue light
Nanoscale Optical Surfaces, no polishing required
>>>>
Precision Device-accurate
Utilizing Innovative Mold Injection Technology, optical surface formed in a single step, polishing-free
Control the Position of the Second Principal Plane in Optics, improve surgical prognosisTestPrecision
Diopter Tolerance±0.20 D, improving surgical accuracy
Scan the QR code on the poster to add our assistant and reserve your spot for the live broadcast!
Shi Baona
Henan Saimeishi Biotechnology Co., Ltd. General Manager
Beijing Institute of Technology Molecular Biology and Biochemistry Master's Degree，Working in the Healthcare IndustryOver the past 18 years, I have worked at three publicly listed companies in the high-value medical device sector, handling global regulatory affairs, clinical trials, marketing, and management. With extensive experience, I have led and successfully completed the rapid industrialization and commercialization of multiple high-value medical products, achieving timelines significantly faster than the industry norm.
Wang Yong
Aier Eye Hospital Affiliated to Wuhan University Deputy Director
Chief Physician Associate Professor Doctoral Supervisor; Vice Chair of the Youth Committee, Ophthalmology Branch, Chinese Geriatrics Society; Member, Visual Rehabilitation Professional Committee, Chinese Association of Rehabilitation Medicine; Vice Chair, Cataract Subcommittee, China Non-Public Medical Institutions Association; Deputy Head, Cataract Study Group, Aier Eye Hospital Group; Council Member, Wuhan Medical Association; Wuhan“May 1st” Model Worker, specializing in the correction of high myopia, presbyopia, and astigmatism, femtosecond laser surgery, and various complex cataract surgeries.
>>>>
About Cymeris
Simeisi is a Sino-US joint venture established by senior management and expert technical teams from the U.S. ophthalmic industry in collaboration with Haohai Biological Technology, a company listed on both the Hong Kong Stock Exchange and the Shanghai STAR Market. Leveraging globally leading injection-molding technology for intraocular lenses (IOLs), proprietary high-performance raw materials, and advanced optical designs protected by independent invention patents, Simeisi aims to build the world’s largest R&D, manufacturing, and production base for premium IOLs. Committed to serving the global market, the company provides high-quality medical products to ophthalmic patients both domestically and internationally. Its products have received support under the National 13th Five-Year Plan Major Special Projects. Covering a full range of premium IOL products, Simeisi’s offerings are characterized by clarity, stability, and precision, owing to advancements in raw materials, optical design, and injection-molding processes. With performance exceeding international standards, its products are recognized in both developed and developing countries worldwide.
About VCBeat's New Product Selection
“Artery Select New Product Debut” is a live-streaming program under the “Artery Select” brand, dedicated to supporting medical enterprises in launching innovative products. The program’s mission is: to empower the milestone launch of every medical innovation product.
Scan the QR code below to contact the assistant and schedule a live stream.
(If already added, please proactively contact the assistant.)
